Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Krause

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|September 4, 2015
Interim results from a phase 3 Ebola vaccine study in GuineaPhilip R Krause
Biologicals : Journal of the International Association of Biological Standardization|September 25, 2009
Goals of stability evaluation throughout the vaccine life cyclePhilip R Krause
Biologicals : Journal of the International Association of Biological Standardization|October 24, 2009
An annual vaccine: seasonal influenzaTeeranart Jivapaisarnpong, Philip R Krause
The Journal of Infectious Diseases|March 6, 2020
Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus VaccinesPhilip R Krause, Jeff Roberts
Biologicals : Journal of the International Association of Biological Standardization|September 29, 2009
Stability evaluation of vaccinesTimothy Schofield, Philip R Krause
Science (New York, N.Y.)|June 23, 2018
Evaluating human trials: FDA's rolePhilip R Krause, Marion F Gruber
Expert Review of Vaccines|April 28, 2017
Regulating vaccines at the FDA: development and licensure of Zika vaccinesMarion F Gruber, Philip R Krause
Vaccine|January 16, 2019
Towards dynamic monitoring of cell cultures using high throughput sequencingShasta D McClenahan, Philip R Krause
The New England Journal of Medicine|October 16, 2020
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up ConsiderationsPhilip R Krause, Marion F Gruber
PDA Journal of Pharmaceutical Science and Technology|December 6, 2014
The potential role of advanced technologies for virus detection in development and regulation of vaccinesShasta D McClenahan, Philip R Krause
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|September 4, 2015
Interim results from a phase 3 Ebola vaccine study in GuineaPhilip R Krause
Biologicals : Journal of the International Association of Biological Standardization|September 25, 2009
Goals of stability evaluation throughout the vaccine life cyclePhilip R Krause
Biologicals : Journal of the International Association of Biological Standardization|October 24, 2009
An annual vaccine: seasonal influenzaTeeranart Jivapaisarnpong, Philip R Krause
The Journal of Infectious Diseases|March 6, 2020
Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus VaccinesPhilip R Krause, Jeff Roberts
Biologicals : Journal of the International Association of Biological Standardization|September 29, 2009
Stability evaluation of vaccinesTimothy Schofield, Philip R Krause
Science (New York, N.Y.)|June 23, 2018
Evaluating human trials: FDA's rolePhilip R Krause, Marion F Gruber
Expert Review of Vaccines|April 28, 2017
Regulating vaccines at the FDA: development and licensure of Zika vaccinesMarion F Gruber, Philip R Krause
Vaccine|January 16, 2019
Towards dynamic monitoring of cell cultures using high throughput sequencingShasta D McClenahan, Philip R Krause
The New England Journal of Medicine|October 16, 2020
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up ConsiderationsPhilip R Krause, Marion F Gruber
PDA Journal of Pharmaceutical Science and Technology|December 6, 2014
The potential role of advanced technologies for virus detection in development and regulation of vaccinesShasta D McClenahan, Philip R Krause
Pageof 7